- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
VA Won't Research Medical Marijuana for Chronic Pain or PTSD Among Veterans
An inquiry by 10 Democrats on the House Committee on Veterans’ Affairs into whether or not the Department of Veterans Affairs (VA) would research medical marijuana in veterans suffering from posttraumatic stress disorder (PTSD) and chronic pain was met with denial.
An inquiry by 10 Democrats on the House Committee on Veterans’ Affairs into whether or not the Department of Veterans Affairs (VA) would research medical marijuana in veterans suffering from posttraumatic stress disorder (PTSD) and chronic pain was met with denial.
In a letter to Representative Tim Walz, D-Minnesota, ranking member of the Committee on Veterans’ Affairs, VA Secretary David Shulkin, MD, wrote in a letter that the VA would not conduct research into medical marijuana because federal law prohibits it. The law also prohibits the VA from referring veterans to any projects researching medical marijuana.
Walz and his fellow Democrats had reached out to Shulkin and the VA because they felt the VA was “uniquely situated to pursue research” into medical marijuana due to its access to world-class researchers and history of service to veterans. He added that “VA research into medical marijuana for veterans suffering from chronic pain and posttraumatic stress disorder is past due…”
Shulkin noted in his response that there is “a rapidly increasing body of evidence” that supports other treatments for chronic pain, such as exercise, yoga, mindfulness, acupuncture, and cognitive behavioral therapy.
“I have heard the stories of veterans who have used cannabis medicinally to help them cope with physical and psychological injuries of war," Walz said in a statement in response to the letter. “Not only have I heard these stories, but I know Secretary Shulkin, who still practices medicine at VA, has heard them as well. That is why I found VA's response to my October 26 letter so disappointing and unacceptable.”
Chronic pain is pervasive among veterans. In 2015, the VA reported that about 60% of veterans returning from combat deployment suffer from chronic pain. Only 30% of Americans nationwide experience chronic pain. A survey by the American Legion found that 22% of veterans are currently using marijuana to treat a medical condition, and that 92% of all veterans support research into medical marijuana.
On January 16, Walz and his fellow Democrats wrote another letter to Shulkin as a follow up to his response.
“While we share your dedication to improving the care of veterans with chronic pain and PTSD, we are concerned VA has not explored all treatment options,” they wrote. “We urge you to join us and the 90% of veterans who are in favor of VA research into medical cannabis.”
How Can Digital Care Programs Aid Those With Chronic Musculoskeletal Pain?
June 9th 2020On this episode of Managed Care Cast, we speak with Jeffrey Krauss, MD, chief medical officer of Hinge Health and Stanford Clinical assistant professor, about the efficacy of a 12-week digital care program aimed to reduce lower back and knee pain in a real-world population.
Listen
Understanding the Impact of Inappropriate Opioid Prescribing Practices
April 19th 2019Deaths from drug overdoses have become the leading cause of death for Americans under age 50, which can largely be attributed to prescription opioids. Due to the role of prescription opioids, understanding prescribing patterns and identifying inappropriate prescribing are crucial for changing the course of the epidemic.
Listen
MBSR Reduced Pain Perception in Patients With Migraine
December 19th 2020The finding about mindfulness-based stress reduction (MBSR) was a secondary outcome of the double-blinded, randomized, placebo-controlled clinical trial. The primary outcome—a reduction in the frequency of migraines—was not reached.
Read More
